We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

Light therapy is emerging as a promising, non-pharmacological treatment for Alzheimer’s disease, offering significant ...

They report a recent clinical trial has demonstrated the potential of focused ultrasound to safely reduce amyloid plaques, a key marker of Alzheimer's disease, without the need for medication.

Company executives said each treatment type they are studying has multibillion-dollar potential, including Alzheimer's disease psychosis, agitation and cognition, along with bipolar disease and ...

There are currently 23 drugs in phase 2 and 3 trials ... next year - but results of two studies in agitation related to Alzheimer’s were mixed. Although one study met an endpoint assessing ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...